We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
With dozens of clinical trials of hydroxychloroquine as a COVID-19 treatment currently in the planning or enrollment stages, there are mounting concerns that the drug’s risks could outweigh the benefits for COVID-19 patients. Read More